Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Kansas City Heart Rhythm Institute

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Device: WATCHMAN; Device: LARIAT LAA

Study type: Observational

Funder types: Other

Identifiers

NCT01695564

13240

Details and patient eligibility

About

Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In the last two decades the number of hospitalizations for AF has increased two- to three-fold. More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac disorder that results in systemic emboli. Patients with AF are 5 times more likely to have a stroke compared with those without AF.

This registry will collection information on two devices that are used to treat AF. The WATCHMAN and LARIAT. The differences in techniques and subsequent effects of the two devices on outcomes related to AF has not been studied. This study will look to compare the two devices to see how the outcomes may vary.

Enrollment: 169 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have had a LARIAT LAA device occlusion

Exclusion criteria

• Patients who have PFO/ASD/critical carotid artery (>70% blockage) disease and hemorrhagic strokes

Trial design

169 participants in 2 patient groups

WATCHMAN

Description:

Patients that had the WATCHMAN device implanted

Treatment:

Device: WATCHMAN

LARIAT LAA Device

Description:

patients that had LARIAT LAA device implanted

Treatment:

Device: LARIAT LAA